Paul J Escher1, Albert Tu2, Susan Kearney3, Matthew Wheelwright1, Joseph Petronio2, Meysam Kebriaei2, Sivakumar Chinnadurai4, Robert J Tibesar5. 1. University of Minnesota Medical School, Minneapolis, MN, USA. 2. Children's Minnesota Department of Neurosurgery, Minneapolis, MN, USA. 3. Children's Minnesota Center for Bleeding and Clotting Disorders, Minneapolis, MN, USA. 4. Children's Minnesota ENT and Craniofacial Surgery, Minneapolis, MN, USA. 5. Children's Minnesota ENT and Craniofacial Surgery, Minneapolis, MN, USA. Robert.tibesar@childrensmn.org.
Abstract
PURPOSE: To assess the success of a protocol using preoperative erythropoietin (EPO) and iron with perioperative tranexamic acid (TXA) in reducing blood transfusion in sagittal craniosynostosis surgery. METHODS: A retrospective chart review of all sagittal craniosynostosis patients undergoing open repair at our institution since 2010 was conducted. A novel protocol of preoperative EPO with iron and perioperative TXA, along with a shift away from automatic transfusion, was initiated in 2014. Perioperative hemoglobin levels, length of stay, and transfusion rates were compared between the historical control and the study group receiving the protocol. RESULTS: A total of 36 patients met inclusion criteria. Twenty-eight patients were male and 8 were female. Twenty-two patients were in the control group receiving neither TXA nor EPO and automatically received a transfusion, while 14 were in the study group and received the full protocol. There were no significant demographic differences between groups. Within the control group, 100% of patients were transfused compared with 14.3% of the study group (p < 0.0001). The study group also had a shorter postoperative length of stay in the hospital (mean, 3.4 days; range, 3-6) than the control (mean, 4 days; range, 2-5.5, p = 0.038). The study group had a higher preoperative hemoglobin than the control (13.6 vs. 11.8 g/dL, p = 0.0001). CONCLUSION: Our protocol of preoperative EPO and iron with perioperative TXA increased the preoperative hemoglobin and was associated with a low transfusion rate without negatively impacting postoperative course.
PURPOSE: To assess the success of a protocol using preoperative erythropoietin (EPO) and iron with perioperative tranexamic acid (TXA) in reducing blood transfusion in sagittal craniosynostosis surgery. METHODS: A retrospective chart review of all sagittal craniosynostosispatients undergoing open repair at our institution since 2010 was conducted. A novel protocol of preoperative EPO with iron and perioperative TXA, along with a shift away from automatic transfusion, was initiated in 2014. Perioperative hemoglobin levels, length of stay, and transfusion rates were compared between the historical control and the study group receiving the protocol. RESULTS: A total of 36 patients met inclusion criteria. Twenty-eight patients were male and 8 were female. Twenty-two patients were in the control group receiving neither TXA nor EPO and automatically received a transfusion, while 14 were in the study group and received the full protocol. There were no significant demographic differences between groups. Within the control group, 100% of patients were transfused compared with 14.3% of the study group (p < 0.0001). The study group also had a shorter postoperative length of stay in the hospital (mean, 3.4 days; range, 3-6) than the control (mean, 4 days; range, 2-5.5, p = 0.038). The study group had a higher preoperative hemoglobin than the control (13.6 vs. 11.8 g/dL, p = 0.0001). CONCLUSION: Our protocol of preoperative EPO and iron with perioperative TXA increased the preoperative hemoglobin and was associated with a low transfusion rate without negatively impacting postoperative course.
Authors: Susan M Goobie; Petra M Meier; Luis M Pereira; Francis X McGowan; Randy P Prescilla; Laurie A Scharp; Gary F Rogers; Mark R Proctor; John G Meara; Sulpicio G Soriano; David Zurakowski; Navil F Sethna Journal: Anesthesiology Date: 2011-04 Impact factor: 7.892
Authors: John F Teichgraeber; James E Baumgartner; Amy L Waller; Scott M Reis; Marshall T Stafford; Laura E Hollinger; Jaime Gateno; James J Xia Journal: J Craniofac Surg Date: 2009-09 Impact factor: 1.046